p53 expression in low grade dysplasia in Barrett's esophagus: Correlation with interobserver agreement and disease progression

American Journal of Gastroenterology

Volumn 97, Issue 10, 2002, Pages 2508-2513

  Skacel, Marek ^a   Petras, Robert E ^a   Rybicki, Lisa A ^a   Gramlich, Terry L ^a   Richter, Joel E ^a   Falk, Gary W ^a   Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN; PROTEIN P53;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DYSPLASIA; ENDOSCOPIC BIOPSY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MODELS, STATISTICAL; OBSERVER VARIATION; SENSITIVITY AND SPECIFICITY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036792677     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04390-3     Document Type: Article

References (20)

1. Falk GW, Rice TW, Goldblum JR, et al. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1998;49:170-6.
2. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-12.
3. Lee RG. Dysplasia in Barrett's esophagus. Am J Surg Pathol 1985;9:845-52.
4. Rice TW, Falk GW, Achkar E, et al. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993;88:1832-6.
5. Reid BJ, Haggitt RC, Rubin CE, et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988;19:166-78.
6. Montgomery E, Bronner E, Goldblum J, et al. Diagnostic reproducibility of dysplasia in Barrett's esophagus: Reaffirmation. Hum Pathol 2001;32:368-78.
7. Khan S, Do KA, Kuhnert P, et al. Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: An endoscopic study. Pathology 1998;30:136-40.
8. WAFI/CIPI/SDII gene products in Barrett's esophagus and adenocarcinoma of the esophagus and esophagogastric junction. Hum Pathol 1996;27:1211-20.
9. Symmans PJ, Linehan JM, Brito MJ, et al. p53 Expression in Barrett's esophagus, dysplasia, and adenocarcinoma using antibody DO-7. J Pathol 1994;173:221-6.
10. Hamelin R, Fléjou JF, Muzeau F, et al. TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus. Gastroenterology 1994;107:1012-8.
11. Neshat K, Sanchez CA, Galipeau PC, et al. p53 Mutations in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology 1994;106:1589-95.
12. Rioux-Leclercq N, Turlin B, Sutherland F, et al. Analysis of Ki-67, p53 and Bcl-2 expression in the dysplasia-carcinoma sequence of Barrett's esophagus. Oncol Rep 1999;6:877-82.
13. Krishnadath KK, Tilanus HW, Van Blankenstein M, et al. Accumulation of p53 protein in normal, dysplastic and neoplastic Barrett's esophagus. J Pathol 1995;175:175-80.
14. Younes M, Ertan A, Lechago LV, et al. p53 Protein accumulation is a specific marker of malignant potential of Barrett's metaplasia. Dig Dis Sci 1997;42:697-701.
15. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224:66-71.
16. Weston AP, Sharma P, Topalowski M, et al Low-grade dysplasia in Barrett's esophagus. Variable fate during long-term prospective follow-up. Gastroenterology 1999;117:A-672(abstract).
17. Skacel M, Petras RE, Gramlich TL, et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000;95:3383-8.
18. Jankowski J, Wright N, Meltzer SJ, et al. Molecular evolution of the metaplasia dysplasia adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
19. Bian YS, Osterheld MC, Bosman FT, et al. p53 Gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus. Mod Pathol 2001;14:397-403.
20. Weston AP, Banerjee SK, Sharma P, et al. p53 Protein overexpression in low-grade dysplasia (LGD) in Barrett's esophagus. Immunohistochemical marker predictive of progression. Am J Gastroenterol 2001;96:1355-62.